Uveitis Treatment Market is valued around USD 475.7 Million in 2018 and expected to reach USD 724.8 Million by 2025 with the CAGR of 6.2% over the forecast period.
Increasing demand for advanced healthcare products and rising number of patients affected by Cataract and other eye related diseases are some factors driving the growth of Global Uveitis Treatment Market.
Get Sample Copy of The Activated Alumina Market Report [email protected] https://brandessenceresearch.com/requestSample/PostId/554
*The sample pages of this report is immediately accessible on-demand.**
- Bausch & Lomb
- Santen Pharmaceutical
- Eyegate Pharmaceuticals
- Alimera Sciences
Uveitis disease directly affects the eyes and the most common symptoms of uveitis are eye inflammation and swelling that can destroy eye tissues. Whether it’s human’s eye or any animals', uveitis affects everyone and can lead to poor vision or blindness. It is named as uveitis because mostly the swelling affects the part of eye which called uvea. Basically eye is made of several layers and uvea is the middle layer, it’s between white part of eye and the inner layers of eye which called the sclera. Uvea has three important structures the iris, the ciliary body and the choroid. The Iris is colored circle at the front of eye, the ciliary body helps to focus eye lens and makes fluid that nourishes inside of eye and the choroid is group of blood vessels which gives the nutrition’s to the retina it needs. People who are suffering from AIDS, Ankylosing spondylitis, Behcet’s disease, CMV retinitis, Herpes zoster infection, Histoplasmosis, Kawasaki disease, Multiple sclerosis, Psoriasis, Reactive arthritis, Rheumatoid arthritis etc. have greater risk of having uveitis than normal people.
Global uveitis treatment market is segmented on the basis of type, application and region & country level. On the basis of type, the market is segmented into anterior uveitis, posterior uveitis, intermediate uveitis and Panuveitis. On the basis of application, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and drug stores.
The regions covered in this Uveitis Treatment Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Uveitis Treatment is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Global Uveitis Treatment Market report covers prominent players like Allergan, Bausch & Lomb, Novartis, AbbVie, Santen Pharmaceutical, Eyegate Pharmaceuticals, Alimera Sciences.
Advanced technological requirements in healthcare, increasing disposable income and high expenditure on healthcare are some of the factors driving the market of uveitis treatment. Uveitis can affect eyes through dirt, pollution, viral, fungal, bacterial infections, etc. and uveitis cause cataract. Cataract is responsible for worlds around 51% of blindness which is about 20 million people. Smokers have more risk of uveitis and of blindness. There are around 1.2 million people who are smokers, there is a huge number of smokers some of them are suffering from diseases and 80% of them are from low and middle income countries. Thus, all these factors are expected to foster the growth of this market.
However, high cost of treatment and lack of skilled professionals can restrain the market growth. In spite of this, technological advancement, increasing numbers of hospitals, diagnostic centers, online treatments are some factors which can provide various opportunities for the further growth of the market.
North America is Expected to Dominate the Global Uveitis Treatment Market.
North America is expected to dominate the Global Uveitis Treatment owing to the high investment in this field. In addition, research and development by leading players to develop new innovative products in this region is also fostering the market growth. For example, Allergan expanded REFRESH portfolio with new REFRESH, RELIEVA Lubricant Eye Drop Product Line. The annual direct medical cost in the US is estimated to USD 117 million. Uveitis accounts 10% of blindness globally. 60%-80% uveitis patient occur in patient in third to sixth decade of life with an age of occurrence of 35. The prevalence of uveitis is estimated 17 per 100000 in Europe which is comparable to the US. Uveitis is one of the major reasons for the birth of cataract and it accounts for 30%–50% of blindness in most Asian countries.
Key Benefits for Market Report–
Global market report covers in depth historical and forecast analysis.
Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global market report helps to identify opportunities in market place.
Global market report covers extensive analysis of emerging trends and competitive landscape.
Uveitis Treatment Market Segmentation:–
By Product Type: - Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, Panuveitis
By Application:- Hospital Pharmacies, Retail Pharmacies,Online Pharmacies, Drug Store
By Regional & Country Analysis
North America, US, Mexico, Chily, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, South Korea, Japan, India, Southeast Asia, Latin America, Brazil, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa
Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at [email protected]